Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SPL submission deadline nears

This article was originally published in The Tan Sheet

Executive Summary

Beginning June 1, firms must electronically submit to FDA drug listings, establishment registrations for OTC products and labeler codes. The agency will accept paper submissions postmarked only through May 31. After that date, FDA will accept data for OTC and veterinary medicine products only submitted electronically in a Structured Product Labeling format (1"The Tan Sheet" Aug. 28, 2006, p. 12)

You may also be interested in...

Paperless Drug Code System Will Allow OTC Listings On DailyMed

FDA's proposed electronic listing system for national drug codes will help the agency expand its electronic labeling system to include OTC drugs, among other products

BrightGene Bets On Remdesivir Amid Patent Questions

Despite many uncertainties, Suzhou-based BrightGene sees a bet on generic remdesivir worthy of a $700,000 investment.

QUOTED. 17 February 2020. Ralph Ives.

The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.   





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts